| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/06/2006 | US7056912 Heteroaryl derivatives and their use as medicaments |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056907 Mandelic acid derivatives and their use as thrombin inhibitors |
| 06/06/2006 | US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction |
| 06/06/2006 | US7056348 Comprises mixing 5-(2,4-dimethoxyphenyl)-1,3,3-trimethyl-2-methylene-indoline and carbonyl compound (4-hydroxy-3-methoxy-benzaldehyde) for dyeing keratin fibers (wool, silk, and/or hair) |
| 06/06/2006 | CA2213526C Stabilizer mixtures |
| 06/06/2006 | CA2210049C Stabilizer mixtures |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/06/2006 | CA2166800C 4-substituted piperidine derivatives useful as neurokinin antagonists |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006058338A2 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 06/01/2006 | WO2006058012A2 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | WO2006057983A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | WO2006057961A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | WO2006057921A2 Piperidinyl piperidine tachykinin receptor antagonists |
| 06/01/2006 | WO2006057870A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057868A1 Antithrombotic diamides |
| 06/01/2006 | WO2006057860A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006057397A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
| 06/01/2006 | WO2006056815A1 Indole-2-carboxylic acid amides |
| 06/01/2006 | WO2006056108A1 Nitromethylene derivatives and their use |
| 06/01/2006 | WO2006036015A3 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 06/01/2006 | WO2006033943A3 Pyrazole kinase modulators and methods of use |
| 06/01/2006 | WO2006033844A3 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators |
| 06/01/2006 | WO2006028957A8 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 06/01/2006 | WO2005061467A3 Piperazine derivatives as bradykinin antagonists |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116385 Novel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116381 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-ben-zamide for treating mutated-ret kinase associated diseases |
| 06/01/2006 | US20060116380 Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 06/01/2006 | US20060116366 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/01/2006 | US20060116363 Tricyclic derivatives as ltd4 antagonists |
| 06/01/2006 | US20060116362 Nobel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116357 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115676 Phenanthroline compound and light-emitting device |
| 06/01/2006 | CA2590349A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2589237A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
| 06/01/2006 | CA2588881A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2588713A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | CA2587888A1 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/01/2006 | CA2587853A1 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | CA2587256A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 06/01/2006 | CA2586883A1 Piperidinyl piperidine tachykinin receptor antagonists |
| 05/31/2006 | EP1661887A1 Method for manufacture of sertindole |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660492A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660491A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 05/31/2006 | EP1660483A1 8-(1-piperazinyl)-quinoline derivatives and their use in the treatment of cns disorders |
| 05/31/2006 | EP1660482A1 3- [(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino] -methyl}-1-methyl-1h -benzimidazol-5-car bonyl)-pyridine-2-yl-amino -propionic acid ethyl ester metha ne sulphonate and use thereof as a medicament |
| 05/31/2006 | EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 05/31/2006 | EP1660480A1 A process for the preparation of cilostazol and of the intermediates thereof |
| 05/31/2006 | EP1660479A1 Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors |
| 05/31/2006 | EP1660478A1 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 05/31/2006 | EP1660477A1 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 05/31/2006 | EP1660476A1 Haloalkyl- and piperidine-substituted benzimidazole-derivatives |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660458A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 05/31/2006 | EP1660456A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 05/31/2006 | EP1660447A1 Cyclic amine base-1 inhibitors having a heterocyclic substituent |
| 05/31/2006 | EP1660444A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660440A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660092A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/31/2006 | EP1660091A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 05/31/2006 | EP1660090A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/31/2006 | EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 05/31/2006 | EP1527052B1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/31/2006 | EP1453512B1 Acetylene derivatives having mglur 5 antagonistic activity |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1408960B1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumour treatment |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1780822A Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) |
| 05/31/2006 | CN1780820A Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 05/31/2006 | CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |